healthsystemcio.com

healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.

  • Subscribe
  • Advertise
  • About
    • Our Team
    • FAQs/Policies
    • Podcasts
    • Social Media
    • Contact
    • Privacy & Data Protection Policy
    • Terms of Service
  • Advisory Panel
  • Webinars
    • 5/24-Improving the Patient Call Experience
    • 5/26-Keys to Keeping Compliant
    • 6/2-Training Clinicians on Key Apps
    • 6/7-Ensuring Cloud Security
    • 6/14-Leading Remote Workforces
    • On-Demand Webinar Library

  • Subscribe
  • Advertise
  • About
    • Our Team
    • FAQs/Policies
    • Podcasts
    • Social Media
    • Contact
    • Privacy & Data Protection Policy
    • Terms of Service
  • Advisory Panel
  • Webinars
    • 5/24-Improving the Patient Call Experience
    • 5/26-Keys to Keeping Compliant
    • 6/2-Training Clinicians on Key Apps
    • 6/7-Ensuring Cloud Security
    • 6/14-Leading Remote Workforces
    • On-Demand Webinar Library

KLAS: Third-Party Portals Getting Locked Out By MU 2

09/17/2013 By Mark Allphin Leave a Comment

Mark Allphin, Senior Research Director, KLAS Enterprises

Mark Allphin, Senior Research Director, KLAS Enterprises

Meaningful Use Stage 2 requirements are pushing patient portals to the top of the CIO’s priority list — particularly EMR vendor products that offer increased interoperability, according to new data from KLAS.

In the report, a large majority (84 percent) of providers identified EMR integration as their primary portal selection criterion, while compatibility with other systems/devices was the top-requested development focus. The news isn’t great for third-party solutions, which are losing ground to EMR-specific products that are better equipped for the more engaging aspects of MU 2 such as sending reminders for follow-up care and providing specific educational content.

“MU Stage 2 is clearly aiding the EMR vendors in this segment,” said report author and research director Mark Allphin. “However, there are advantages to looking outside your EMR. Many providers are still trying to determine which portal solution will best meet their needs, now and in the future as they continue to engage their patients on a deeper level.”

EMR-agnostic products Medseek and Intuit are taking a hit, according to KLAS, which found that a quarter of Intuit’s users reported plans to leave, and Medseek is losing customers due to unmet product expectations, high costs, or an enterprise EMR strategy.

KLAS_Portals_9-2013

The top performing portal was athenahealth, earning high marks with the ease of uploading patient information and the portal’s flexible platform for educational content and patient messaging (via email, phone, or text). In addition, athenahealth and Intuit were the only vendors to rate above average in critical patient engagement categories.

Opportunities remain, however, for more vendors to make a move, as a large number of providers are still determining which portal solution will best meed their needs, the report noted.

Other vendors featured in the research include Allscripts (Jardogs), Cerner, eClinicalWorks, Epic, Greenway Medical, NextGen, and Vitera.

 

Share

Related Posts:

  • KLAS: Third-Party Vendors Cornering the ACO Market
  • KLAS: Ambulatory Practices Overconfident in MU Readiness
  • KLAS: Third Parties Edging Software Makers In Remote Hosting Race
  • KLAS: Quality Reporting Dwarfs Other MU Concerns
  • The Risky Business Of Third-Party Vendors

Filed Under: Integration, Meaningful Use Stage 2, Patient Portals Tagged With: Allscripts, athenahealth, Cerner, eClinicalWorks, Epic, Greenway, Intuit Health, KLAS, Mark Allphin, Medseek, NextGen, Vitera

Share Your Thoughts Cancel reply

You must be logged in to post a comment.

To register, click here.

Content by Topic

Partner Sponsors

 

.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Copyright © 2022 HealthsystemCIO.com.